NCT00523328View on ClinicalTrials.gov

BG9924 in Combination With Methotrexate Extension of Study 104RA203 (NCT 00458861)

PHASE2TerminatedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions
Rheumatoid Arthritis
Interventions
DRUG

BG9924

dosage administered as per Biogen-idec protocol

Trial Locations (4)

4000

Coordinating Research Site, Liège

94305

Coordinating Research Site, Palo Alto

H9P 2V4

Coordinating Research Site, Toronto

NE1 4LP

Coordinating Research Site, Newcastle

Sponsors

Lead Sponsor

Biogen
All Listed Sponsors
lead

Biogen

INDUSTRY